select trial semaglutide ppt was published today in NEJM. Below, I summarize the trial and the drug in this thread.... - Dr Shailesh Singh Semaglutide Indication Opportunity: From CDK,

Gastroenterology 86(2):274280 Ritzel R, Orskov C, Holst JJ, Nauck MA (1995) Pharmacokinetic, insulinotropic, and glucagonostatic properties of GLP-1 [7-36 amide] after subcutaneous injection in healthy volunteers

However, its important to monitor how you feel and report any persistent or bothersome symptoms to your healthcare provider, as adjustments in dosage or medication may be necessary for comfort and safety

This is one of the most important reasons to work with a dietitian while on medication

However, reinforcement of weight loss strategies and healthy lifestyle changes remain imperative for long-term success